309 related articles for article (PubMed ID: 10713670)
1. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
[TBL] [Abstract][Full Text] [Related]
2. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
[TBL] [Abstract][Full Text] [Related]
4. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
5. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
World J Surg Oncol; 2004 May; 2():13. PubMed ID: 15132743
[TBL] [Abstract][Full Text] [Related]
6. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
Zhigang Z; Wenlu S
Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
[TBL] [Abstract][Full Text] [Related]
7. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
8. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
Dubey P; Wu H; Reiter RE; Witte ON
Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
[TBL] [Abstract][Full Text] [Related]
9. Role of prostate stem cell antigen in prostate cancer research.
Jalkut MW; Reiter RE
Curr Opin Urol; 2002 Sep; 12(5):401-6. PubMed ID: 12172427
[TBL] [Abstract][Full Text] [Related]
10. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen: a prospective therapeutic and diagnostic target.
Raff AB; Gray A; Kast WM
Cancer Lett; 2009 May; 277(2):126-32. PubMed ID: 18838214
[TBL] [Abstract][Full Text] [Related]
12. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
[TBL] [Abstract][Full Text] [Related]
13. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
Ross S; Spencer SD; Holcomb I; Tan C; Hongo J; Devaux B; Rangell L; Keller GA; Schow P; Steeves RM; Lutz RJ; Frantz G; Hillan K; Peale F; Tobin P; Eberhard D; Rubin MA; Lasky LA; Koeppen H
Cancer Res; 2002 May; 62(9):2546-53. PubMed ID: 11980648
[TBL] [Abstract][Full Text] [Related]
14. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
[TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.
Han KR; Seligson DB; Liu X; Horvath S; Shintaku PI; Thomas GV; Said JW; Reiter RE
J Urol; 2004 Mar; 171(3):1117-21. PubMed ID: 14767283
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients.
Taeb J; Asgari M; Abolhasani M; Farajollahi MM; Madjd Z
Pathol Res Pract; 2014 Jan; 210(1):18-23. PubMed ID: 24183365
[TBL] [Abstract][Full Text] [Related]
20. The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.
Chizari M; Fani-Kheshti S; Taeb J; Farajollahi MM; Mohsenzadegan M
Recent Pat Anticancer Drug Discov; 2021; 16(1):73-83. PubMed ID: 33176663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]